Most antipsychotic conversations start with the active ingredient. Asenapine is one of the few where the route of administration is just as interesting. Sold as Saphris sublingual tablets and as Secuado transdermal patches, asenapine is the only second-generation antipsychotic that is absorbed primarily through the lining of the mouth — not the gut. That single fact shapes nearly everything about how it is dosed, how it feels, and the small list of habits patients have to build around it.
Asenapine is a serotonin–dopamine receptor antagonist approved for schizophrenia and bipolar I disorder, taken sublingually or as a once-daily patch, with a side effect profile centered on sedation, oral numbness, and modest metabolic effects.
Why sublingual?
If asenapine is swallowed, almost none of it reaches the bloodstream — bioavailability drops below 2% because of extensive first-pass metabolism by the liver. Held under the tongue for ten minutes, bioavailability climbs to roughly 35%. The FDA Saphris prescribing information spells out the practical rules: place the tablet under the tongue, let it dissolve completely, and avoid eating or drinking for ten minutes afterward. Patients who chew, crush, or swallow the tablet effectively skip a dose.
The transdermal patch (Secuado)
For people who cannot manage the sublingual routine, asenapine is also approved as a once-daily transdermal patch. The Secuado label describes a steady release over 24 hours, applied to the upper arm, upper back, abdomen, or hip. Local skin reactions — redness, irritation — are common; rotating sites helps. The patch removes oral absorption issues entirely and produces flatter plasma levels than the sublingual route, which can soften peak-related sedation.
How asenapine works pharmacologically
Asenapine is a "multi-acting receptor-targeted" antipsychotic. It binds with high affinity to serotonin 5-HT2A, 5-HT2C, 5-HT7, dopamine D2 and D3, and alpha-1 and alpha-2 adrenergic receptors, with relatively little anticholinergic activity. The serotonin-rich receptor profile is part of why it has a relatively favourable EPS profile compared with high-potency typicals — and why some patients find it more activating, others more sedating, depending on how the receptor mix lands for them.
FDA-approved indications
- Schizophrenia in adults — acute and maintenance treatment
- Bipolar I disorder — acute treatment of manic or mixed episodes as monotherapy or with lithium or valproate; also maintenance monotherapy
- Bipolar I in pediatric patients (10–17) — manic or mixed episodes
Typical dosing
For schizophrenia in adults, the FDA-recommended starting and target dose is 5 mg twice daily, which can be raised to 10 mg twice daily if needed. For bipolar mania, 10 mg twice daily is the typical starting point. Doses higher than 10 mg twice daily have not been shown to add efficacy in trials but do add side effects. The patch comes in 3.8 mg/24 h, 5.7 mg/24 h, and 7.6 mg/24 h strengths.
What patients tend to notice early
Oral hypoaesthesia
A temporary numbness or tingling in the mouth and tongue, typically lasting under an hour after each dose. Most people get used to it; some find it intolerable. Eating or drinking too soon worsens both the numbness and the absorption.
Sedation
Common, especially in the first weeks, often improves with time. Many prescribers schedule the larger dose at bedtime to make the sedation work for sleep.
Akathisia
An inner restlessness — pacing, foot-tapping — that is dose-related. Lowering the dose, adding propranolol, or switching can help. See our akathisia guide.
Weight gain
Average weight gain on asenapine is modest — generally less than olanzapine or quetiapine, similar to risperidone. Metabolic monitoring is still recommended.
Allergic reactions
The FDA added a warning in 2011 about serious allergic reactions to asenapine, including anaphylaxis, angioedema, low blood pressure, fast heartbeat, swollen tongue, and trouble breathing. Reactions can occur after the first dose. Anyone with hives, swelling of the face or throat, or breathing difficulty after a dose should seek emergency care and not take it again.
You develop swelling of the lips, tongue, or throat; difficulty breathing; widespread hives; or fainting after taking asenapine.
Cardiovascular effects
Asenapine can prolong the QTc interval on ECG, modestly. Risk rises in combination with other QT-prolonging drugs or with electrolyte abnormalities. Orthostatic hypotension can occur, especially during initial titration; standing up slowly helps. See our QT prolongation overview and orthostatic hypotension article.
Drug interactions and metabolism
Asenapine is metabolised by direct glucuronidation and by CYP1A2 oxidation. Strong CYP1A2 inhibitors (such as fluvoxamine) can raise asenapine levels meaningfully. Smoking, which induces CYP1A2, can lower levels — quitting may raise them. Always tell your prescriber about smoking changes and any new medications.
Who tends to do well on asenapine
- People who want a relatively weight-neutral atypical option
- People with bipolar I who need both schizophrenia-style symptom coverage and mania control
- People who have had EPS on high-potency typicals
- People who can build the sublingual habit (or who switch to the patch)
Who might choose differently
- People who cannot reliably wait ten minutes after dosing before eating or drinking
- People with significant cardiac arrhythmia history
- People with prior allergic reaction to asenapine
- People who need a once-daily oral option (asenapine sublingual is twice daily)
Practical questions to ask your prescriber
- Should we start with sublingual or the patch?
- What schedule will work with my eating and drinking habits?
- What baseline labs and ECG do I need?
- What should I do if I notice mouth numbness lasting longer than expected?
The big picture
Asenapine is not a first-line agent for most people, but it occupies a useful niche. The unusual route makes it more demanding than a swallowable pill — and easier than many depots. The patch expands its appeal further. For patients who want a moderately weight-neutral atypical, who can build a reliable dosing habit, and who tolerate the oral side effects, it can be a stable foundation for recovery. For others, a swallowable pill or different agent makes more sense. Whether asenapine fits is best decided in conversation with a prescriber who knows your full picture.
This article is for educational purposes only and is not medical advice. Information is summarised from publicly available FDA labelling and peer-reviewed literature. Always consult your prescribing clinician before starting, stopping, or changing any medication.